Multiple 5-HT receptors in passive avoidance: Comparative studies of p-chloroamphetamine and 8-OH-DPAT

Neuropsychopharmacology

Volumn 22, Issue 2, 2000, Pages 168-190

  Misane, Ilga ^a   Ögren, Sven Ove ^a   Med Sc , ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HT receptors; 8 OH DPAT; Dopamine; m Chlorophenylpiperazine (mCPP); p Chloroamphetamine (PCA); Passive avoidance

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CHLORAMPHETAMINE; KETANSERIN; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PINDOLOL; RACLOPRIDE; RECEPTOR SUBTYPE; REMOXIPRIDE; RITANSERIN; RO 60 0491; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; SPIPERONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; MALE; NEUROTRANSMISSION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0034141526     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00109-8     Document Type: Article

References (117)

1. Adell A., Sarna G.S., Hutson P.H., Curzon G. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br J Pharmacol. 97:1989;206-212.
2. Agnati L.F., Zoli M., Strömberg I., Fuxe K. Intercellular communication in the brain. Wiring versus volume transmission Neuroscience. 69:1995;711-726.
3. Altman H.J., Nordy D.A., Ögren S.O. Role of serotonin in memory. Facilitation by alaproclate and zimeldine Psychopharmacology. 84:1984;496-502.
4. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Temporal characterization of subcortical nuclei in mnemonic processes. Results of tetrodotoxin reversible inactivation studies in the rat Arch Ital Biol. 136:1998;279-296.
5. Aulakh C.S., Wozniak K.M., Haas M., Hill J.L., Zohar J., Murphy D.L. Food intake, neuroendocrine, and temperature effects of 8-OH-DPAT in the rat. Eur J Pharmacol. 146:1988;253-259.
6. Banfi S., Cornelli U., Fonio W., Dorigotti L. A screening method for substances potentially active on learning and memory. J Pharmacol Methods. 8:1982;255-263.
7. 2 receptor subtypes. A family re-united? TIPS. 16:1995;105-110.
8. Beique J.C., Lavoie N., de Montigny C., Debonnel G. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol. 349:1998;129-132.
9. 1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav. 33:1989;821-827.
10. Bilkei-Gorzo A., Gyertyan I., Levay G. mCPP-induced anxiety in the light-dark box in rats - A new method for screening anxiolytic activity. Psychopharmacology. 136:1998;291-298.
11. Blier P., Lista A., De Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine-1A receptors in the dorsal raphe and hippocampus. I. Effect of spiperone J Pharmacol Exp Ther. 265:1993;7-15.
12. Bunin M.A., Wightman R.M. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake. An investigation of extrasynaptic transmission J Neurosci. 18:1998;4854-4860.
13. 1A receptor agonist, impairs performance in a passive avoidance task. Eur J Pharmacol. 211:1992;227-234.
14. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology. 92:1987;14-24.
15. Crespi D., Mennini T., Gobbi M. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine, and (+)-fenfluramine. Br J Pharmacol. 121:1997;1735-1743.
16. Curzon G. Stereotyped and other motor responses to 5-hydroxytryptamine receptor activation. Cooper S.J., Dourish C.T. Neurobiology of Stereotyped Behaviour. 1990;142-167 University Press, Oxford, UK.
17. Curzon G., Kennett G.A. m-Cpp. A tool for studying behavioral responses associated with 5-HT1c receptors TIPS. 11:1990;181-182.
18. Davis M. Pharmacological and anatomical analysis of fear conditioning. NIDA Res Monogr. 97:1990;126-162.
19. Davis M., Sheard M.H. p-Chloroamphetamine (PCA). Acute and chronic effects on habituation and sensitization of the acoustic startle response in rats Eur J Pharmacol. 35:1976;261-273.
20. Descarries L., Audet M.A., Doucet G., Garcia S., Oleskevich S., Seguela P., Soghomonian J.J., Watkins K.C. Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationships. Ann NY Acad Sci. 600:1990;81-92.
21. Descarries L., Beaudet A., Watkins K.C. Serotonin nerve terminals in adult rat neocortex. Brain Res. 100:1975;563-588.
22. 3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse. 9:1991;14-26.
23. Dourish C.T., Hutson P.J., Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propyloamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology. 86:1985;197-204.
24. Evenden J.L., Angeby-Möller K. Effects of 8-hydroxy-2-(di-n-propyloamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology. 102:1990;485-491.
25. 7 receptor antagonist J Med Chem. 41:1998;655-657.
26. 2B receptor antagonist J Med Chem. 38:1995;855-857.
27. 1A receptor antagonist, WAY 100635. Eur J Pharmacol. 281:1995;81-88.
28. Gallagher M., Chiba A.A. The amygdala and emotion. Curr Opin Neurobiol. 6:1996;221-227.
29. Gewirtz J.C., Davis M. Application of Pavlovian higher-order conditioning to the analysis of the neural substrates of fear conditioning. Neuropharmacology. 37:1998;453-459.
30. Geyer M.A. Serotonergic functions in arousal and motor activity. Behav Brain Res. 73:1996;31-35.
31. 1B receptors with WAY 100,635 and GR 127,935. J Neurochem. 68:1997;1159-1163.
32. Grahame-Smith D.G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis, and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem. 18:1971;1053-1066.
33. Griebel G., Misslin R., Pawlowski M., Vogel E. m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. NeuroReport. 2:1991;627-629.
34. Hamon M, Collin E, Chantrel D, Daval G, Verge D, Bourgoin S, Cesselin F (1990): Serotonin receptors and the modulation of pain. In Besson JM (ed), Serotonin and Pain. Amsterdam: Excerpta Medica, pp 53.
35. Heilman K.M., Gilmore R.L. Cortical influences in emotion. J Clin Neurophysiol. 15:1998;409-423.
36. Henderson M.G., Perry K.W., Fuller R.W. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta, beta-difluoro-p-chloroamphetamine in rats. J Pharmacol Exp Ther. 267:1993;417-424.
37. 2 dopamine receptors J Neurosci. 8:1988;2361-2370.
38. Hjorth S., Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol. 129:1986;131-138.
39. Hoffman B.J., Mezey E., Brownstein M.J. Cloning of a serotonin transporter affected by antidepressants. Science. 254:1991;579-580.
40. Hoyer D. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. Fozard J. Peripheral Actions of 5-HT. 1989;72-99 Oxford University Press, Oxford, UK.
41. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin J.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol Rev. 46:1994;157-203.
42. Hoyer D., Martin G.R. 5-HT receptor classification. Toward a harmonization with the human genome Neuropharmacology. 36:1997;419-428.
43. 2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Eur J Pharmacol. 238:1993;291-296.
44. Hutson P.H., Curzon G. Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour. Br J Pharmacol. 96:1989;801-806.
45. Jackson D.M., Bengtsson A., Johansson C., Cortizo L., Ross S.B. Development of tolerance to 8-OH-DPAT-induced blockade of acquisition of a passive avoidance response. Neuropharmacology. 33:1994;1003-1009.
46. Jacobs B.L. An animal behavior model for studying central serotonergic synapses. Life Sci. 19:1976;777-785.
47. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev. 72:1992;165-229.
48. 2A receptor-immunoreactive neuronal processes in the brain stem of rats. A double immunolabelling analysis. NeuroReport. 9:1998;2505-2511.
49. 1 agonists affect passive avoidance in rats. Adv Biosci. 70:1988;81-84.
50. 1A receptor antagonist, NAD-299. J Pharmacol Exp Ther. 283:1997;216-225.
51. Johnson M.P., Huang X.M., Oberlender R., Nash J.F., Nichols D.E. Behavioral, biochemical, and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine. Eur J Pharmacol. 191:1990;1-10.
52. Kehne J.H., McCloskey T.C., Taylor V.L., Black C.K., Fadayel G.M., Schmidt C.J. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther. 260:1992;78-89.
53. Kehne J.H., Padich R.A., McCloskey T.C., Taylor V.L., Schmidt C.J. 5-HT modulation of auditory and visual sensorimotor gating. I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats Psychopharmacology. 124:1996;95-106.
54. 1C receptors and their therapeutic relevance. Curr Opin Invest Drugs. 2:1993;317-362.
55. 1C receptor antagonists. Eur J Pharmacol. 164:1989;445-454.
56. Kirk R.E. Experimental Design. Procedures for the Behavioral Sciences:1968;Brooks/Cole, Belmont, CA.
57. Kovacs G.L., de Wied D. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity. Eur J Pharmacol. 53:1978;103-107.
58. Lalonde R., Vikis-Freibergs V. Manipulations of 5-HT activity and memory in the rat. Pharmacol Biochem Behav. 22:1985;377-382.
59. Lavond D.G., Kim J.J., Thompson R.F. Mammalian brain substrates of aversive classical conditioning. Ann Rev Psychol. 44:1993;317-342.
60. Ledoux J.E., Müller J. Emotional memory and psychopathology. Philos Trans Roy Soc Lond B: Biol Sci. 352:1997;1719-1726.
61. 2 receptors Psychopharmacology. 112:1993;S40-S54.
62. Lucki I., Nobler M.S. The acute effects of antidepressant drugs on the performance of conditioned avoidance behavior in rats. Pharmacol Biochem Behav. 22:1985;261-264.
63. 1A receptors in the dorsal raphe nucleus. Eur J Pharmacol. 149:1988;9-15.
64. 2 receptors and dopamine metabolism. Relationship between biochemical and behavioral effects of substituted benzamide drugs. Neuropharmacology. 25:1986;187-197.
65. Marona-Lewicka D., Rhee G.S., Sprague J.E., Nichols D.E. Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav. 53:1996;99-105.
66. 1A receptors Brain Res. 739:1996;192-200.
67. 2C receptor agonists. Pharmacological characteristics and therapeutic potential J Pharmacol Exp Ther. 286:1998;913-924.
68. McElroy J.F., Du Pont A.F., Feldman R.S. The effects of fenfluramine and fluoxetine on the acquisition of the conditioned avoidance response in rats. Psychopharmacology. 77:1982;356-359.
69. McNamara M.G., Kelly J.P., Leonard B.E. Some behavioral and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav. 52:1995;479-484.
70. Meneses A., Hong E. Effect of fluoxetine on learning and memory involves multiple 5-HT systems. Pharmacol Biochem Behav. 52:1995;341-346.
71. 4 receptor agonists and antagonists in learning. Pharmacol Biochem Behav. 56:1997;347-351.
72. 2A serotonin receptor binding J Med Chem. 41:1998;5084-5093.
73. Middlemiss D.N. Blockade of the central 5-HT autoreceptor by beta-adrenoreceptor antagonists. Eur J Pharmacol. 120:1986;51.
74. 1A receptor-mediated activity in the rat. A pharmacological characterization of the actions of novel agonists and antagonists J Pharmacol Exp Ther. 264:1993;1364-1376.
75. 1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 125:1998;499-509. a.
76. 1A receptor-mediated response by the neuropeptide galanin in the rat. Eur J Neurosci. 10:1998;1230-1240. b.
77. Moret C., Briley M. The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism. J Psychopharmacol. 7:1993;331-337.
78. Murphy D.L., Lesch K.P., Aulakh C.S., Pigott T.A. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev. 43:1991;527-552.
79. Ögren S.O. Forebrain serotonin and avoidance learning. Behavioral and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat Pharmacol Biochem Behav. 16:1982;881-895.
80. Ögren S.O. Central serotonin neurones in avoidance learning. Interactions with noradrenaline and dopamine neurones Pharmacol Biochem Behav. 23:1985;107-123. a.
81. Ögren S.O. Evidence for a role of brain serotonergic neurotransmission in avoidance learning. Acta Physiol Scand. 125(Suppl 544):1985;1-71. b.
82. Ögren S.O. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine. Brain Res Bull. 16:1986;645-660. a.
83. Ögren S.O. Serotonin receptor involvement in the avoidance learning deficit caused by p-chloroamphetamine-induced serotonin release. Acta Physiol Scand. 126:1986;449-462. b.
84. Ögren SO (1996): The behavioral pharmacology of typical and atypical antipsychotic drugs. In Csernansky JG (ed), Handbook of Experimental Pharmacology. Berlin: Springer, pp 225-266.
85. Ögren S.O., Archer T. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile. Psychopharmacology. 114:1994;383-391.
86. Ögren S.O., Berge O.G., Johansson C. Involvement of spinal serotonergic pathways in nociception but not in avoidance learning. Psychopharmacology. 87:1985;260-265.
87. Ögren S.O., Florvall L., Hall H., Magnusson O., Angeby-Moller K. Neuropharmacological and behavioral properties of remoxipride in the rat. Acta Psychiat Scand Suppl. 358:1990;21-26.
88. Ögren S.O., Fuxe K., Archer T., Johansson G., Holm A.C. Behavioural and biochemical studies on the effects of acute and chronic administration of antidepressant drugs on central serotoninergic receptor mechanisms. Adv Biosci. 40:1982;11-19.
89. Ögren S.O., Johansson C. Separation of the associative and nonassociative effects of brain serotonin released by p-chloroamphetamine. dissociable serotoninergic involvement in avoidance learning, pain, and motor function Psychopharmacology. 86:1985;12-26.
90. Ögren S.O., Misane I. Animal models for studying serotonin (5-HT) receptor subtypes. Relationship to 5-HT system pathologies Nucl Med Biol. 25:1998;747-749.
91. 2 receptors. Neuroscience. 61:1994;269-283.
92. Overton DA (1978): Major theories of state dependent learning. In Ho BT, Richards DW III, Chute DL (eds), Drug Discrimination and State Dependent Learning. New York: Academic Press, pp 283.
93. Pauwels P.J. 5-HT 1B/D receptor antagonists. Gen Pharmacol. 29:1997;293-303.
94. Pezzone M.A., Lee W.S., Hoffman G.E., Rabin B.S. Induction of c-Fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res. 597:1992;41-50.
95. 1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur J Pharmacol. 262:1994;77-90.
96. Rigdon G.C., Weatherspoon J.K. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther. 263:1992;486-493.
97. Romano A.G., Harvey J.A. MDMA enhances associative and nonassociative learning in the rabbit. Pharmacol Biochem Behav. 47:1994;289-293.
98. Ruffolo R.R.J., Bondinell W., Hieble J.P. Alpha- and beta-adrenoceptors. From the gene to the clinic. 2. Structure-activity relationships and therapeutic applications J Med Chem. 38:1995;3681-3716.
99. 1A receptor ligands by means of in vivo animal models. Eur J Pharmacol. 315:1996;245-254.
100. Santucci A.C., Knott P.J., Haroutunian V. Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur J Pharmacol. 295:1996;7-17.
101. 1-like receptors. A time to bid goodbye TIPS. 19:1998;311-316.
102. Schmidt C.J., Sullivan C.K., Fadayel G.M. Blockade of striatal 5-hydroxytryptamine-2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analog 3,4-methylenedioxymethamphetamine. J Neurochem. 62:1994;1382-1389.
103. Schuldiner S., Steiner-Mordoch S., Yelin R., Wall S.C., Rudnick G. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol Pharmacol. 44:1993;1227-1231.
104. Seliger D.L. Dose-response effects of d-amphetamine on passive avoidance learning in the rat. Psychopharmacologia. 44:1975;191-193.
105. Seliger D.L. Passive avoidance learning in the rat as functions of d-amphetamine dosage and shock intensity. Psychopharmacology. 54:1977;241-242.
106. Sharp T., Zetterström T., Christmanson L., Ungerstedt U. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett. 72:1986;320-324.
107. Sipes T.A., Geyer M.A. 8-OH-DPAT disruption of prepulse inhibition in rats. Reversal with (+)WAY 100,135 and localization of site of action Psychopharmacology. 117:1995;41-48.
108. 3H]8-OH-DPAT labeling of serotonin uptake sites. Brain Res. 617:1993;159-162.
109. 3H-NAD-299. Naunyn Schmiedebergs Arch Pharmacol. 357:1998;500-507.
110. 7 receptor (long form). Antagonist profile of SB-258719 Br J Pharmacol. 124:1998;1300-1306.
111. 1A receptor and catecholaminergic system in the behavioral response to 8-hydroxy-2-(di-n-propyloamino)tetralin in the rat. Eur J Pharmacol. 106:1984;271-282.
112. Trulson M.E., Jacobs B.L. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol. 36:1976;149-154.
113. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol. 313:1991;643-668.
114. Wall S.C., Gu H., Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines. Amphetamine specificity for inhibition and efflux Mol Pharmacol. 47:1995;544-550.
115. Whitton P., Curzon G. Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology. 100:1990;138-140.
116. 4 receptors Naunyn Schmiedebergs Arch Pharmacol. 356:1997;712-720.
117. Zuardi A.W. 5-HT-related drugs and human experimental anxiety. Neurosci Biobehav Rev. 14:1990;507-510.